Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma with Peg-Interferon Alpha 2a and Ribavirin in Hepatitis C Non-Responders
NCT00148863Phase 2Completed
- Sponsor
- ANRS
- Start
- Jun 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon gamma-1b in hepatitis C (HCV), sponsored by ANRS. Primary endpoint: Virological response (HCV RNA non detectable) at 28 weeks. Started Jun 2004; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00148863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148863.